The FDA late Wednesday granted emergency use authorization for a third dose of the Pfizer COVID-19 vaccine to those over the age of 65 and a wide swath of American workers at higher risk of infection.
which was published ahead of peer review suggests the efficacy of the single dose J&J shot has fallen to about 78% against symptomatic infection during the Delta surge.
Doran Fink, MD, a deputy director of the FDA’s Division of Vaccines, told the committee the agency was working as quickly as possible on Moderna’s submission. Those answers are coming, though. John Beigel, MD, associate director of clinical research at the National Institute of Allergy and Infectious Diseases, revealed that the federal government has a study under way to see what happens when the vaccines are mixed.
Pfizer had originally applied to the FDA for a an amendment to its FDA approval, which would have given doctors a freer hand to prescribe third doses as they saw fit, in patients as young as 16.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And OlderPfizer said a third shot would restore the effectiveness of its COVID-19 vaccine to about 95%.
Read more »
FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and olderThe FDA granted emergency use authorization for a booster dose of Pfizer's Covid-19 vaccine in people 65 and older, people at high risk of severe disease and people whose jobs put them at risk of infection.
Read more »
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe FDA authorized Pfizer booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.
Read more »
The FDA Authorized Pfizer Booster Shots For Older People And Those At High RiskThe emergency authorization will allow a third dose of the Pfizer-BioNTech vaccine to be given to people over 65, healthcare workers, and others at high risk of severe COVID-19.
Read more »
The FDA Could Soon Review the Pfizer Vaccine for Children Ages 5 to 11If all goes as planned, millions of children could be vaccinated by Halloween.
Read more »